Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
133 studies found for:    MMP-9
Show Display Options
Rank Status Study
1 Completed MMP-9 Monitoring Particulate Cerebral Embolisation
Condition: Cerebral Embolic Damage
Intervention: Procedure: vein blood collection
2 Completed Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions
Conditions: Precancerous Conditions;   Oral Cancer
Intervention:
3 Unknown  The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels
Condition: Cerebral Infarction
Interventions: Drug: Erigeron Injection;   Drug: placebo
4 Recruiting Multicentre Trial Of Serum Levels Of MMP-9 As A Biomarker Of Endoleak
Condition: Endoleak After Endovascular Aneurysm Repair
Intervention:
5 Completed Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients
Condition: Cystic Fibrosis
Interventions: Drug: Doxycycline;   Other: placebo
6 Completed Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?
Condition: Glaucoma
Intervention: Procedure: Blood Sample
7 Unknown  Biomarkers for Prognosis of Glioblastoma (GBM)
Condition: Glioblastoma
Intervention:
8 Recruiting Evaluation of Dentinal Fluid for the Presence of Matrix Metalloproteinase 9 (MMP-9) in Pulpal Inflammation
Condition: Pulpitis
Intervention: Procedure: Collection of dentinal fluid using a cellulose membrane
9 Completed Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia
Condition: Schizophrenia
Intervention: Dietary Supplement: Sarcosine
10 Recruiting Point of Care Testing of Inflammatory Markers in Tears
Condition: Dry Eye Syndrome
Interventions: Other: Eye inflammation;   Other: Without eye inflammation
11 Completed
Has Results
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
Conditions: Myocardiopathies;   Ischemia, Myocardial;   Arrythmia;   Death, Sudden, Cardiac
Intervention:
12 Completed Effect of Montelukast on Remodelling Markers in Asthmatic Children
Condition: Asthma
Interventions: Drug: Montelukast;   Drug: placebo
13 Recruiting Clinical Study of Relationship Between Granulocyte Activation, HDAC2 and Severe Asthma
Condition: Asthma
Intervention: Other: severe asthma group
14 Completed A Comparative Study of Volume Replacement With HES 130/0.4 Versus Ringer's Lactate (RL) Regarding Their Effects on Inflammatory Biomarkers (Cytokines and Matrix Metalloproteinases) Responses to Major Abdominal Surgery.
Condition: Postoperative Inflammation
Interventions: Other: Ringer's Lactate;   Other: HES 130/0.4 and Ringer's Lactate
15 Completed Influence of MMP on Brain AVM Hemorrhage
Conditions: Arteriovenous Malformations;   Cavernous Angiomas;   Brain Aneurysms
Intervention: Drug: Doxycycline or Placebo
16 Completed Effects of Vaginal Lactoferrin Administration Prior to Genetic Amniocentesis on Inflammatory Mediators
Condition: Pregnancy
Intervention: Drug: Lactoferrin
17 Completed Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: Insulin Glulisine;   Drug: Insulin
18 Completed Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.
Condition: Prostate Cancer
Intervention: Drug: PCK3145
19 Completed Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid
Condition: Bullous Pemphigoid
Intervention: Other: Blood sample for dosages of cytokines (IL-17 and IL-23) and of the protease MMP-9
20 Completed
Has Results
A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal
Condition: Dry Eye Syndromes
Intervention: Other: No intervention

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.